1. Corporate Officers - H
2. Ho Maykin

Insider Trading History of Ho Maykin

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ho Maykin since 2019. This trader's CIK number is 1646395. At the time of last reporting, Ho Maykin was the Director of Agios Pharmaceuticals, Inc.. (stock ticker symbol AGIO). Also see all insider trading activities at Agios Pharmaceuticals, Inc..

Note that in the past Ho Maykin also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Ho Maykin

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	AGIO	0	$0	0	$0	2,120	$0
2024	AGIO	0	$0	0	$0	3,388	$0
2023	AGIO	0	$0	0	$0	4,975	$0
2022	AGIO	0	$0	0	$0	1,585	$0
2021	AGIO	0	$0	0	$0	1,686	$0
2020	AGIO	0	$0	0	$0	1,878	$0
2019	AGIO	0	$0	0	$0	1,400	$0

Yearly summary of insider trading at Fibrogen Inc (FGEN) by Ho Maykin

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	FGEN	0	$0	8,520	$146,842	0	$0

Insider trading activities at 2 companies by Ho Maykin:

1. Agios Pharmaceuticals, Inc. (AGIO)

2. Fibrogen Inc (FGEN)

Table 1. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Ho Maykin

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-06-20	AGIO	Option Ex	2,120	.00	0
2024-06-13	AGIO	Option Ex	3,388	.00	0
2023-06-21	AGIO	Option Ex	4,975	.00	0
2022-05-20	AGIO	Option Ex	1,585	.00	0
2021-05-28	AGIO	Option Ex	1,686	.00	0
2020-05-29	AGIO	Option Ex	1,878	.00	0
2019-05-31	AGIO	Option Ex	1,400	.00	0

Table 2. Insider trading of Fibrogen Inc (FGEN) by Ho Maykin

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-06-08	FGEN	Sale	8,520	17.23	146,842

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ho Maykin (Director of Agios Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month